Axovant Science Ltd (AXON)
#AXON dropped -73.90% closed at $6.33 today after MINDSET P3 data failed to met primary endpoint. Alzhemier's disease have no cure drug in the market because every companies entered P3 has failed. This shouldn't be a surprised to anyone.
Luckily, this company is not one trick pony. There are two more upcoming data one is Q4 2017 and one is Q1 2018. As noted on biotech upcoming data. I'm expecting a bounce from this level.
What are your thoughts?